Spero Therapeutics (SPRO) Revenue (2017 - 2026)
Spero Therapeutics (SPRO) posted Revenue of $258,000 for Q1 2026, down 95.6% from $5.87 million a year earlier and down 99.4% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Revenue (2017 - 2026) Analysis & Trends
For FY2025, Spero Therapeutics' Revenue came in at $66.8 million, up 39.2% from FY2024.
- Annual Revenue shows a five-year compound annual growth rate of 48.2% (FY2020 to FY2025).
- In prior years, Spero Therapeutics' Revenue was $47.98 million in FY2024 (-53.8%), $103.78 million in FY2023 (+94.0%), $53.51 million in FY2022 (+193.1%) and $18.26 million in FY2021 (+95.7%).
- The Q1 2026 figure stands as the lowest quarterly Revenue since Q2 2017.
- On a year-over-year basis, Revenue increased in three of the last eight quarters, with growth averaging 21.3%.
- The strongest year-over-year quarter for Revenue in the past five years was Q1 2024, with growth of 347.9%; the weakest was Q1 2026, with a decline of 95.6%.
- According to Business Quant data, Revenue for the three prior quarters was $41.3 million (Q4 2025), $5.44 million (Q3 2025) and $14.19 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Spero Therapeutics | 68.40 Mn | -127.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 258,000.00 |
| Dec 31, 2025 | 41.30 Mn |
| Sep 30, 2025 | 5.44 Mn |
| Jun 30, 2025 | 14.19 Mn |
| Mar 31, 2025 | 5.87 Mn |
| Dec 31, 2024 | 15.04 Mn |
| Sep 30, 2024 | 13.47 Mn |
| Jun 30, 2024 | 10.20 Mn |
| Mar 31, 2024 | 9.27 Mn |
| Dec 31, 2023 | 73.52 Mn |
| Sep 30, 2023 | 25.47 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 2.07 Mn |
| Dec 31, 2022 | 47.44 Mn |
| Sep 30, 2022 | 2.01 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | 2.07 Mn |
| Dec 31, 2021 | 2.74 Mn |
| Sep 30, 2021 | 3.06 Mn |
| Jun 30, 2021 | 5.15 Mn |
API Access
Spero Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();